NURS 6521 Week 9 Sickle Cell Disease Therapeutic Management Essay Assignment Paper
NURS 6521 Week 9 Sickle Cell Disease Therapeutic Management Essay Assignment Paper
Hence the name, Sickle Cell Disease causes hemoglobin cells to change from a smooth and malleable disc shape into a rigid sickle shape (National Heart, Lung, and Blood Institute, 2016). This genetic disorder results in a lifetime of anemia and severe painful episodes. hypoxia and/or death of tissue and vital organs. Known as a genetic disorder, SCD affects mainly minority populations such as African Americans, Hispanics, and Middle Easterns.
Order now for original nursing paper on NURS 6521 Week 9 Sickle Cell Disease Therapeutic Management Essay Assignment Paper from Best Nursing Writers
Therapeutic Management
Pharmacotherapeutics are based on the presenting symptoms of the Sickle Cell disease patient. Symptoms can include pain in chest, extremities, back, and other parts of the body. NSAIDs are used for mild episodes as long as they are not contraindicated. Medications for severe pain are individually based but usually include opioids as first line treatment. Additional supportive interventions such as proper oxygenation, hydration, and maintenance of temperature are necessary. Acute SCD crises are easily exacerbated by stress and introductions of infections in the body. Cultures should be promptly collected to effectively target and treat the offending organism. SC crises may also be treated with a blood transfusion that essentially decreases the percentage of HbS and reducing SCD symptoms (National Heart, Lung, and Blood Institute, 2014). The first new drugs for SCD in 20 years, Endari (L-glutamine oral powder), has been shown to decrease exacerbation’s as well (U. S. Food and Drug Administration, 2017).
